3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Phase 3
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pancreatic Neoplasms
1
Colorectal Neoplasia
1
Barrett Esophagus
1
Interventions
Gemcitabine
6
Irinotecan
5
Oxaliplatin
4
Magnetic Resonance Spectroscopy
4
Surgical Procedures, Operative
3
Specimen Handling
3
Leucovorin
3
Fluorouracil
3
Albumin-Bound Paclitaxel
3
130-nm albumin-bound paclitaxel
3
palbociclib
2
olaparib
2
cobimetinib
2
Radiosurgery
2
Positron-Emission Tomography
2
Oncolytic Virotherapy
2
Nivolumab
2
Ketamine
2
Immunoglobulin G
2
Immune Checkpoint Inhibitors
2
Disulfides
2
Cyclophosphamide
2
Capecitabine
2
Biopsy
2
tremelimumab
1
trastuzumab biosimilar HLX02
1
toripalimab
1
sonidegib
1
semaglutide
1
pimonidazole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase EARLY_PHASE1
×
Pancreatic Neoplasms
×
Omeprazole
×
Clear all
NCT04930991
2026-06-01
OU202005AJ
University of Oklahoma
Phase EARLY_PHASE1
Terminated
25 enrolled